Sell these ASX 200 stocks now: Goldman Sachs

The broker is warning investors that these stocks could tumble from current levels.

| More on:
Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now could be the time to sell the two ASX 200 stocks in this article.

That's the view of analysts at Goldman Sachs, which have slapped sell ratings on them this morning.

Which ASX 200 stocks are sells?

The first stock that could be a sell is stock exchange operator ASX Ltd (ASX: ASX).

In response to its investor day update this week, the broker has reiterated its sell rating and $55.45 price target on its shares.

Based on its current share price of $58.14, this implies potential downside of 4.5% for investors over the next 12 months.

Commenting on the ASX 200 stock's investor day event, the broker said:

Elevated Capex to persist at ~$160-180m p.a. across FY25 to FY27 implying ~$510m cumulative spend (at midpoint) across that 3 year period on CHESS, derivatives & trading + maintenance capex. We note that while ASX's technology roadmap extends beyond FY27, ASX does guide to capex reducing into FY28. 2) D&A will continue to be a drag on earnings growth: ASX guidance implies ~$50m D&A charge in FY25. We think D&A will gradually increase in a staged manner based on ASX's guided capex spend and as system releases go live through FY25-FY28+ using a useful life of about 7-10 years. We now forecast a more material increase in D&A by FY30 (assuming all major projects go live before then).

Reece Ltd (ASX: REH)

Another ASX 200 stock that has copped a sell rating is Reece.

This morning, Goldman has initiated coverage on the plumbing parts company's shares with a sell rating and $23.35 price target. This implies potential downside of 12.1% for investors over the next 12 months.

The broker appears to believe the market is too optimistic on the company's US expansion and feels it will take time to have a meaningful impact. It explains:

US provides growth optionality…over time. Limited geographic spread and low network density in a fragmented market supports store roll out growth opportunity with margin expansion to complement market growth over time. However, assessing the network density of competitors like Ferguson and Watsco suggests this is a long-dated opportunity. We forecast a 7% 3yr EBITDA CAGR (USD) for this segment.

In light of this and with the ASX 200 stock trading on higher than normal multiples, the broker feels it is fully valued today. It adds:

REH is trading in excess of its historical average premium to the S&P ASX200 (0.6x standard deviations above its 5yr average). Compared to its peer set, REH is also trading above its historic premiums despite lagging the peer set on metrics such as EBIT margins and EBIT growth (note we forecast a 5% EBIT CAGR for REH, in line with Visible Alpha consensus). We initiate at Sell.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker looking at the share price.
Broker Notes

Broker ratings on 6 ASX shares about to join the ASX 200

These 6 companies will enter the ASX 200 in the December quarter rebalance. Should you buy them?

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40% in 2026

Looking for big returns? Analysts think these shares could beat the market.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Analysts name 3 ASX shares to buy this week

Analysts have good things to say about these shares.

Read more »